OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
600655 Shanghai Yuyuan Tourist Mart
- 5.62
- 0.000.00%
Not Open Apr 1 15:00 CST
21.89BMarket Cap175.63P/E (TTM)
5.68High5.61Low101.73KlotVolume5.63Open5.62Pre Close57.30MTurnover0.26%Turnover Ratio175.63P/E (Static)3.89BShares7.0352wk High0.62P/B21.86BFloat Cap4.8852wk Low6.18Limit Up3.89BShs Float23.28Historical High5.06Limit Down1.25%Amplitude-2.19Historical Low0.19Dividend TTM5.63Avg Price54.43KlotAsk3.38%Div YieldTTM100Lot Size45.89KlotBid
Shanghai Yuyuan Tourist Mart Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -19.30%46.92B | -8.72%36.1B | 0.47%27.57B | 12.56%17.22B | 15.83%58.15B | 15.57%39.55B | 21.86%27.44B | 23.06%15.3B | -3.41%50.2B | 5.43%34.22B |
| Operating revenue | -19.30%46.92B | -8.72%36.1B | 0.47%27.57B | 12.56%17.22B | 15.83%58.15B | 15.57%39.55B | 21.86%27.44B | 23.06%15.3B | -3.41%50.2B | 5.43%34.22B |
| Other operating revenue | 23.93%469.82M | ---- | 38.42%247.85M | ---- | -30.93%379.1M | ---- | -41.44%179.06M | ---- | 27.03%548.89M | ---- |
| Interest income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Commission income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Premiums earned | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total operating cost | -16.83%48.67B | -8.18%36.93B | 0.71%28.01B | 13.05%17.14B | 15.50%58.52B | 16.00%40.22B | 21.75%27.81B | 22.16%15.16B | 2.31%50.67B | 8.62%34.67B |
| Operating cost | -18.81%40.54B | -8.23%31.39B | 0.64%23.9B | 12.90%14.86B | 20.90%49.94B | 20.63%34.2B | 27.63%23.75B | 29.57%13.16B | 4.41%41.31B | 8.23%28.35B |
| Operating tax surcharges | -10.08%638.26M | -4.00%323.19M | -1.43%244.77M | -19.95%108.56M | -37.16%709.85M | -26.75%336.67M | -34.59%248.33M | -40.69%135.62M | -55.13%1.13B | -38.07%459.62M |
| Operating expense | -9.97%2.77B | -15.95%1.93B | -8.98%1.35B | -1.34%800.06M | 8.23%3.07B | 11.60%2.29B | 10.64%1.49B | 9.21%810.96M | 8.84%2.84B | 13.95%2.05B |
| Administration expense | -14.19%2.75B | -8.89%1.97B | -5.94%1.37B | 11.83%793.03M | -12.50%3.2B | -9.51%2.16B | -3.82%1.46B | -11.45%709.12M | 6.38%3.66B | 9.98%2.39B |
| Financial expense | 27.13%1.93B | 11.48%1.29B | 35.55%1.11B | 76.58%569.88M | -4.38%1.52B | -13.36%1.16B | -12.83%818.31M | -30.79%322.73M | 21.19%1.58B | 39.55%1.34B |
| -Interest expense (Financial expense) | 21.45%1.88B | 24.32%1.37B | 23.80%915.4M | 35.62%484.24M | 5.56%1.55B | -2.56%1.1B | -7.58%739.44M | -11.60%357.06M | 16.12%1.47B | 23.85%1.13B |
| -Interest Income (Financial expense) | 28.17%-72.15M | 31.69%-55.08M | 50.57%-23.03M | -78.96%-37.6M | -0.67%-100.44M | -0.12%-80.64M | 44.53%-46.6M | 24.40%-21.01M | 40.26%-99.77M | 40.04%-80.54M |
| Research and development | -41.26%48.82M | -50.50%36.36M | -48.99%23.71M | -49.40%11.84M | -43.18%83.12M | -10.71%73.46M | -12.84%46.49M | 44.80%23.4M | 69.06%146.29M | 60.93%82.27M |
| Credit Impairment Loss | 89.53%-14.56M | 192.13%7.67M | 307.64%29.21M | -148.34%-26.63M | -75.52%-139.05M | 53.72%-8.32M | -135.94%-14.07M | -189.25%-10.72M | -63.90%-79.22M | -197.23%-17.98M |
| Asset Impairment Loss | -150.91%-950.89M | -60.16%-168.93M | -55.40%-164.95M | 164.32%7.3M | -1,592.92%-378.98M | -3,686.98%-105.47M | -5,120.18%-106.15M | -75.87%2.76M | 66.67%-22.39M | -327.94%-2.79M |
| Other net revenue | -22.01%2.12B | -18.17%2.46B | -27.16%2.07B | -22.42%214.63M | -56.53%2.71B | 88.31%3.01B | 121.39%2.84B | -34.94%276.66M | 158.54%6.24B | 4.41%1.6B |
| Fair value change income | 2,287.31%893.85M | 1,354.78%272.65M | 236.55%130.02M | 331.11%17.76M | -92.18%37.44M | -95.89%18.74M | -91.13%38.63M | -153.59%-7.68M | 44.72%478.55M | 7,298.06%455.75M |
| Invest income | -33.96%1.97B | -27.48%2.15B | -32.00%1.94B | -26.37%191.06M | -46.68%2.98B | 194.56%2.96B | 291.13%2.86B | -27.72%259.48M | 201.97%5.59B | -25.31%1.01B |
| Net open hedge income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Including: Investment income associates | -82.57%110.21M | -62.51%224.41M | -70.75%155.79M | -40.13%133.37M | -25.11%632.26M | 19.24%598.52M | 38.37%532.69M | 257.96%222.78M | -21.38%844.21M | -46.41%501.94M |
| Exchange income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Asset deal income | -68.03%25.3M | -45.77%26.02M | 5,036.57%27.51M | -159.76%-48.18K | -25.18%79.12M | -53.22%47.99M | -100.62%-557.18K | -99.26%80.61K | -61.55%105.75M | -29.15%102.58M |
| Other revenue | 43.60%195.32M | 90.11%174.75M | 55.14%106.89M | -23.08%25.19M | -21.05%136.02M | 72.15%91.92M | 92.53%68.9M | 86.90%32.75M | 132.65%172.28M | 8.50%53.39M |
| Operating profit | -84.25%368.05M | -30.18%1.63B | -33.92%1.64B | -28.68%296.85M | -59.54%2.34B | 104.13%2.33B | 156.73%2.48B | -6.99%416.25M | 18.73%5.77B | -44.70%1.14B |
| Add:Non operating Income | -15.85%49.54M | 47.16%40.09M | 59.51%33.01M | 18.54%6.22M | -44.27%58.87M | -64.67%27.24M | -66.78%20.7M | -90.32%5.25M | -20.66%105.64M | -48.55%77.1M |
| Less:Non operating expense | 25.14%101.48M | -28.00%48.95M | -57.41%23.73M | 28.25%9.79M | -1.56%81.09M | -36.23%67.99M | -32.57%55.73M | -35.65%7.64M | -32.80%82.38M | 7.84%106.61M |
| Total profit | -86.34%316.12M | -29.32%1.62B | -32.59%1.65B | -29.14%293.28M | -60.09%2.31B | 105.89%2.29B | 158.55%2.44B | -15.51%413.86M | 18.96%5.8B | -47.43%1.11B |
| Less:Income tax cost | 50.23%745.24M | 264.99%651.01M | 113.30%629.59M | 22.24%147.05M | -75.29%496.07M | -47.90%178.36M | 12.13%295.17M | 25.56%120.29M | 93.14%2.01B | -5.91%342.35M |
| Net profit | -123.60%-429.12M | -54.19%967.01M | -52.64%1.02B | -50.19%146.23M | -52.04%1.82B | 174.30%2.11B | 215.10%2.15B | -25.50%293.57M | -1.15%3.79B | -56.06%769.54M |
| Net profit from continuing operation | -123.60%-429.12M | -54.19%967.01M | -52.64%1.02B | -50.19%146.23M | -52.04%1.82B | 174.30%2.11B | 215.10%2.15B | -25.50%293.57M | -1.15%3.79B | -56.06%769.54M |
| Net income from discontinuing operating | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Less:Minority Profit | -169.39%-554.38M | -55.04%-192.39M | -77.13%-124.56M | -34.34%-34M | -285.34%-205.79M | -976.78%-124.09M | -8,115.32%-70.32M | -136.22%-25.31M | 67.01%111.04M | -121.45%-11.52M |
| Net profit of parent company owners | -93.81%125.26M | -48.12%1.16B | -48.53%1.14B | -43.48%180.23M | -45.00%2.02B | 186.14%2.23B | 225.83%2.22B | -1.63%318.88M | -2.35%3.68B | -53.99%781.06M |
| Earning per share | ||||||||||
| Basic earning per share | -93.86%0.032 | -48.00%0.299 | -48.34%0.295 | -42.68%0.047 | -45.27%0.521 | 183.25%0.575 | 224.43%0.571 | -2.38%0.082 | -2.06%0.952 | -53.65%0.203 |
| Diluted earning per share | -93.86%0.032 | -47.91%0.299 | -48.25%0.295 | -42.68%0.047 | -45.27%0.521 | 184.16%0.574 | 223.86%0.57 | -2.38%0.082 | -1.96%0.952 | -53.88%0.202 |
| Other composite income | -2,146.50%-101.03M | -200.69%-186.74M | 144.98%27.11M | 19.79%-9.49M | 103.00%4.94M | -114.46%-62.1M | -23.01%-60.26M | 43.40%-11.83M | -467.28%-164.7M | 853.49%429.47M |
| Other composite income of parent company owners | -1,824.74%-101.62M | -209.89%-186.04M | 147.62%28.19M | 26.06%-8.81M | 103.57%5.89M | -114.08%-60.04M | -22.79%-59.19M | 36.11%-11.91M | -407.52%-164.86M | 950.79%426.5M |
| Other composite income of minority owners | 161.66%588.96K | 66.04%-702.46K | -0.91%-1.08M | -940.60%-681.88K | -700.40%-955.12K | -169.72%-2.07M | -36.59%-1.07M | 103.59%81.12K | 101.81%159.08K | 143.20%2.97M |
| Total composite income | -129.08%-530.15M | -61.92%780.26M | -49.98%1.04B | -51.46%136.74M | -49.72%1.82B | 70.87%2.05B | 229.97%2.09B | -24.50%281.74M | -6.54%3.63B | -29.23%1.2B |
| Total composite income of parent company owners | -98.84%23.64M | -55.25%973.35M | -45.81%1.17B | -44.15%171.43M | -42.25%2.03B | 80.11%2.17B | 241.30%2.16B | 0.47%306.97M | -8.03%3.52B | -26.70%1.21B |
| Total composite income of minority owners | -167.86%-553.79M | -53.05%-193.09M | -75.99%-125.64M | -37.48%-34.68M | -285.93%-206.75M | -1,374.23%-126.16M | -75,082.73%-71.39M | -137.31%-25.23M | 92.64%111.2M | -118.26%-8.56M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.